Literature DB >> 14764131

Criterion validity, test-retest reliability and sensitivity to change of the St George Urinary Incontinence Score.

A L Blackwell1, W Yoong, K H Moore.   

Abstract

OBJECTIVE: To assess the criterion validity, test-retest reliability and the sensitivity to change after treatment of the St George Urinary Incontinence Score (SGUIS). PATIENTS AND METHODS: Women presenting with urinary incontinence completed two SGUIS tests one week apart. A frequency-volume chart (FVC) was completed before the first attendance and the women had a 1-h pad test before treatment. Patients were treated conservatively under the care of a urogynaecologist or nurse continence advisor, or surgically with an open or laparoscopic colposuspension. After treatment, the SGUIS, FVC and 1-h pad test were repeated.
RESULTS: The SGUIS correlated moderately well with the number of leaks per week (Spearman's r = 0.610, 95% confidence interval 0.516-0.689, P < 0.001) but less well with the 1-h pad test loss (r = 0.257, 0.124-0.380, P = 0.002). The test-retest reliability was acceptable, as the mean (SD) difference between the first and second SGUIS was 0.337 (2.675), with limits of agreement of -5.012 to -5.686. The change in the SGUIS after treatment correlated well with the improvement in the number of leaks per week (r = 0.742, 0.662-0.805, 156 samples, P < 0.001) but not as well with the change in 1-h pad test loss (r = 0.531, 0.405-0.636, 151, P < 0.001), although the trend was similar.
CONCLUSION: The criterion validity of the SGUIS appeared adequate for both the number of leaks per week on the FVC and leakage on the 1-h pad test. The statistical reproducibility of the test was adequate and appeared more responsive to change after treatment than the other measures. The score is suitable for rapid self-administration by patients with a range of incontinence types, unlike most other currently available test instruments.

Entities:  

Mesh:

Year:  2004        PMID: 14764131     DOI: 10.1111/j.1464-410x.2003.04610.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  2 in total

1.  Update: the "Contiform" intravaginal device in four sizes for the treatment of stress incontinence.

Authors:  W A Allen; H Leek; A Izurieta; K H Moore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

2.  Is objective cure of mild undifferentiated incontinence more readily achieved than that of moderate incontinence? Costs and 2-year outcome.

Authors:  R O'Sullivan; A Simons; S Prashar; P Anderson; M Louey; K H Moore
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.